Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2
- PMID: 25643210
- DOI: 10.1021/jm501778s
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2
Abstract
High throughput screening followed by a lead generation campaign uncovered a novel series of urea containing morpholinopyrimidine compounds which act as potent and selective dual inhibitors of mTORC1 and mTORC2. We describe the continued compound optimization campaign for this series, in particular focused on identifying compounds with improved cellular potency, improved aqueous solubility, and good stability in human hepatocyte incubations. Knowledge from empirical SAR investigations was combined with an understanding of the molecular interactions in the crystal lattice to improve both cellular potency and solubility, and the composite parameters of LLE and pIC50-pSolubility were used to assess compound quality and progress. Predictive models were employed to efficiently mine the attractive chemical space identified resulting in the discovery of 42 (AZD3147), an extremely potent and selective dual inhibitor of mTORC1 and mTORC2 with physicochemical and pharmacokinetic properties suitable for development as a potential clinical candidate.
Similar articles
-
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014.Bioorg Med Chem Lett. 2013 Mar 1;23(5):1212-6. doi: 10.1016/j.bmcl.2013.01.019. Epub 2013 Jan 18. Bioorg Med Chem Lett. 2013. PMID: 23375793
-
The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.Bioorg Med Chem Lett. 2009 Oct 15;19(20):5950-3. doi: 10.1016/j.bmcl.2009.08.038. Epub 2009 Aug 13. Bioorg Med Chem Lett. 2009. PMID: 19762236
-
A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors.Bioorg Med Chem Lett. 2013 Sep 15;23(18):5097-104. doi: 10.1016/j.bmcl.2013.07.027. Epub 2013 Jul 23. Bioorg Med Chem Lett. 2013. PMID: 23932790
-
Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment.Expert Opin Drug Discov. 2013 Aug;8(8):991-1012. doi: 10.1517/17460441.2013.800479. Epub 2013 May 14. Expert Opin Drug Discov. 2013. PMID: 23668243 Review.
-
Optimization and characterization of a triazole urea dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2).2011 Feb 25 [updated 2013 Mar 7]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2011 Feb 25 [updated 2013 Mar 7]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 23658947 Free Books & Documents. Review.
Cited by
-
Discovery of an Orally Bioavailable Dual PI3K/mTOR Inhibitor Based on Sulfonyl-Substituted Morpholinopyrimidines.ACS Med Chem Lett. 2018 Jun 25;9(7):719-724. doi: 10.1021/acsmedchemlett.8b00167. eCollection 2018 Jul 12. ACS Med Chem Lett. 2018. PMID: 30034607 Free PMC article.
-
Overview of Research into mTOR Inhibitors.Molecules. 2022 Aug 19;27(16):5295. doi: 10.3390/molecules27165295. Molecules. 2022. PMID: 36014530 Free PMC article. Review.
-
Indole hydrazide compound ZJQ-24 inhibits angiogenesis and induces apoptosis cell death through abrogation of AKT/mTOR pathway in hepatocellular carcinoma.Cell Death Dis. 2020 Oct 28;11(10):926. doi: 10.1038/s41419-020-03108-2. Cell Death Dis. 2020. PMID: 33116125 Free PMC article.
-
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.PLoS One. 2015 Jul 6;10(7):e0131400. doi: 10.1371/journal.pone.0131400. eCollection 2015. PLoS One. 2015. PMID: 26148118 Free PMC article.
-
Divergent Synthesis of Cyclopropane-Containing Lead-Like Compounds, Fragments and Building Blocks through a Cobalt Catalyzed Cyclopropanation of Phenyl Vinyl Sulfide.European J Org Chem. 2017 Sep 15;2017(34):5015-5024. doi: 10.1002/ejoc.201701030. Epub 2017 Sep 11. European J Org Chem. 2017. PMID: 28983191 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Miscellaneous